Alliance Boots (A): Too big for his boots? Taking a FTSE 100 company private
The marriage between Boots the Chemist, the UK’s leading retail pharmacy chain, and Alliance UniChem, one of Europe’s largest drug wholesalers, was declared a match made in heaven by the two main instigators of the deal; Sir Nigel Rudd, chairman of Boots, and Stefano Pessina, executive deputy chairman of Alliance UniChem. The £7 billion merger was said to be a true merger of equals and would form a springboard to turn the company into a global health and beauty care company. Both Rudd and Pessina put an enormous amount of time and effort into convincing their respective shareholders to accept the deal. The campaign paid off and the merged company floated on 31 July 2006. Less than eight months later, Pessina took centre stage again for another announcement. In what was seen as a shocking turnaround by many City observers, not to mention by the Alliance Boots investors, he made a formal bid, backed by the private equity firm Kohlberg Kravis Roberts (KKR), to take the company private. It was not simply the speed of the turnaround that was an issue. Pessina was executive deputy chairman of Alliance Boots, managing the strategy and integration of the merged company. He was also the largest individual shareholder with a 15% stake in the company. To complicate matters further, many of the executive and non-executive board members had previous connections with Pessina, as did some of the advisors involved in the proposed deal; Goldman Sachs, acting for Alliance Boots, was simultaneously advising KKR on another deal; and Alliance Boots and KKR were using the same financial PR firm. It was impossible for investors to know where to turn to get an objective view of the situation. Sir Nigel Rudd, as chairman of the board, had his work cut out for him.
Participants should understand 1) that the stewardship of an independent board by the chairman can sometimes be particularly difficult in certain circumstances yet it remains one of his primary responsibilities; 2) that the resolution of multiple conflicts of interest is often not clear cut; 3) that the goal of maximising shareholder value can involve a number of conflicting options and choices; 4) some of the underlying factors driving the private equity sector.
2005-2007
Cranfield University
Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]
Harvard Business School Publishing
60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]
NUCB Business School
1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]
IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information related to case studies, please contact Case Services.
Research Information & Knowledge Hub for additional information on IMD publications
The shadow banking system is back in the spotlight. Hedge funds and private credit vehicles are huge in size and their ties to banks have deepened to the point that trouble in that market could jolt the wider financial system, regulators are warni...
Family-run companies have unique challenges—balancing family interests with the goals of investors and the company itself. Yet there is not enough clarity on how this affects performance in different countries. We wanted to fill that gap. Our work...
Michel Galeazzi and Felix Ackermann, founding partners of the private equity firm Evoco, sat with the rest of the team pondering the latest strategic issues. Evoco had evolved significantly as a fund manager since its creation in 2012, taking adv...
We examine the predictive power of the net asset value (NAV)/price ratio for the LPX50 index, a key benchmark in the field of listed private equity, using monthly data from 2002 to 2024. A risk factor model reveals the index’s significant exposure...
As the rapid decline in biodiversity exacerbates climate risks and threatens human wellbeing, biodiversity credits are emerging as a promising yet challenging mechanism for mobilizing conservation finance. Some scepticism stems from disappointment...
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in FamilyBusiness.org 6 October 2025
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD
Research Information & Knowledge Hub for additional information on IMD publications
in Journal of Portfolio Management August 2025, vol. 51, no. 9, https://doi.org/10.3905/jpm.2025.1.736
Research Information & Knowledge Hub for additional information on IMD publications
in Proceedings of the Royal Society B August 2025, vol. 292, no. 2053, 20250990, https://doi.org/10.1098/rspb.2025.0990
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications